Unveiling 4 Analyst Insights On AnaptysBio
Unveiling 4 Analyst Insights On AnaptysBio
公佈關於AnaptysBio的4項分析師見解
In the preceding three months, 4 analysts have released ratings for AnaptysBio (NASDAQ:ANAB), presenting a wide array of perspectives from bullish to bearish.
在過去的三個月中，有4位分析師發佈了AnaptysBio（納斯達克股票代碼：ANAB）的評級，提出了從看漲到看跌的各種觀點。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您將找到他們最近的評級摘要，揭示了過去30天中情緒的變化，並將其與前幾個月進行了比較。
Analysts have set 12-month price targets for AnaptysBio, revealing an average target of $53.25, a high estimate of $80.00, and a low estimate of $28.00. Surpassing the previous average price target of $30.00, the current average has increased by 77.5%.
分析師已經爲AnaptysBio設定了12個月的目標股價，顯示平均目標股價爲53.25美元，最高估計爲80.00美元，低估值爲28.00美元。超過了之前的30.00美元的平均目標價，目前的平均價格上漲了77.5％。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析師評級：詳細明細
An in-depth analysis of recent analyst actions...
對分析師近期行爲...
登入免費觀看全文
登入/註冊